Skip to main content

Advances in CAR T-Cell Therapy

December 15, 2020

Topics Covered

We invite you to learn more about:

  • Why CAR T-cell (chimeric antigen receptor T-cell) therapy shows promise for blood cancers
  • Approved and emerging CAR T-cell therapies
  • The future of CAR T-cell therapy for blood cancer patients



Iris Isufi, MD
Co-Director, Adult CAR-T-Cell Therapy Program
Yale Cancer Center/Smilow Cancer Hospital
Assistant Professor, Medicine
Yale University School of Medicine
New Haven, CT

Audio Replay

Program Materials

Program Support

Support for this program is provided by Bristol-Myers Squibb; CRISPR Therapeutics; Kite, a Gilead Company; and Novartis.


< Back to Webcasts